247 related articles for article (PubMed ID: 3020161)
1. Reactions of sera from patients with rheumatoid arthritis, systemic lupus erythematosus and infectious mononucleosis to Epstein-Barr virus-induced polypeptides.
Sculley DG; Sculley TB; Pope JH
J Gen Virol; 1986 Oct; 67 ( Pt 10)():2253-8. PubMed ID: 3020161
[TBL] [Abstract][Full Text] [Related]
2. High titer of antibody to the Epstein-Barr virus membrane antigen in sera from patients with rheumatoid arthritis and systemic lupus erythematosus.
Yokochi T; Yanagawa A; Kimura Y; Mizushima Y
J Rheumatol; 1989 Aug; 16(8):1029-32. PubMed ID: 2555505
[TBL] [Abstract][Full Text] [Related]
3. Potential role of the Epstein-Barr virus in systemic lupus erythematosus autoimmunity.
Incaprera M; Rindi L; Bazzichi A; Garzelli C
Clin Exp Rheumatol; 1998; 16(3):289-94. PubMed ID: 9631751
[TBL] [Abstract][Full Text] [Related]
4. Correlation between the presence of antibodies to the Epstein-Barr virus nuclear antigen type 2 and antibodies to the rheumatoid arthritis nuclear antigen in patients with rheumatoid arthritis.
Sculley TB; Pope JH; Hazelton RA
Arthritis Rheum; 1986 Aug; 29(8):964-70. PubMed ID: 3017369
[TBL] [Abstract][Full Text] [Related]
5. Antibody responses against polypeptide components of Epstein-Barr virus-induced early diffuse antigen in patients with connective tissue diseases.
Ngou J; Segondy M; Seigneurin JM; Graafland H
J Med Virol; 1990 Sep; 32(1):39-46. PubMed ID: 2173736
[TBL] [Abstract][Full Text] [Related]
6. Enhancement of Epstein-Barr virus antibody production in systemic lupus erythematosus patients.
Stancek D; Robenský J
Acta Virol; 1979 Mar; 23(2):168-9. PubMed ID: 39442
[TBL] [Abstract][Full Text] [Related]
7. Immune response to different sequences of the EBNA I molecule in Epstein-Barr virus-related disorders and in autoimmune diseases.
Marchini B; Dolcher MP; Sabbatini A; Klein G; Migliorini P
J Autoimmun; 1994 Apr; 7(2):179-91. PubMed ID: 7518683
[TBL] [Abstract][Full Text] [Related]
8. Elevated levels of antibodies to Epstein-Barr virus antigens in sera and synovial fluids of patients with rheumatoid arthritis.
Alspaugh MA; Henle G; Lennette ET; Henle W
J Clin Invest; 1981 Apr; 67(4):1134-40. PubMed ID: 6259211
[TBL] [Abstract][Full Text] [Related]
9. Lack of relationship between the Epstein-Barr virus and the antiperinuclear factor/'perinuclear antigen' system in rheumatoid arthritis.
Buisson M; Berthelot JM; Le Goff P; Chastel C; Lamour A; Seigneurin JM; Youinou P
J Autoimmun; 1994 Aug; 7(4):485-95. PubMed ID: 7980850
[TBL] [Abstract][Full Text] [Related]
10. [Investigation of Epstein-Barr virus and herpes simplex virus markers by serological and molecular methods in patients with rheumatoid arthritis and systemic lupus erythematosus].
Us T; Cetin E; Kaşifoğlu N; Kaşifoğlu T; Akgün Y
Mikrobiyol Bul; 2011 Oct; 45(4):677-83. PubMed ID: 22090298
[TBL] [Abstract][Full Text] [Related]
11. Detection of antibodies to the Epstein-Barr virus nuclear antigens in the sera from patients with systemic lupus erythematosus.
Kitagawa H; Iho S; Yokochi T; Hoshino T
Immunol Lett; 1988 Mar; 17(3):249-52. PubMed ID: 2836302
[TBL] [Abstract][Full Text] [Related]
12. Identification of Epstein-Barr virus-induced polypeptides in P3HR-1 cells by protein immunoblot.
Sculley TB; Sculley DG; Pope JH
J Gen Virol; 1985 May; 66 ( Pt 5)():1113-22. PubMed ID: 2582083
[TBL] [Abstract][Full Text] [Related]
13. Antibody to the rheumatoid arthritis nuclear antigen. Its relationship to in vivo Epstein-Barr virus infection.
Catalano MA; Carson DA; Niederman JC; Feorino P; Vaughan JH
J Clin Invest; 1980 May; 65(5):1238-42. PubMed ID: 6245108
[TBL] [Abstract][Full Text] [Related]
14. Immune response to intermediate filament-associated, Epstein-Barr virus-induced early antigen.
Sairenji T; Nguyen QV; Woda B; Humphreys RE
J Immunol; 1987 Apr; 138(8):2645-52. PubMed ID: 2435803
[TBL] [Abstract][Full Text] [Related]
15. [Clinical study on antibodies against EBV in sera of patients with rheumatoid arthritis].
Zhang X; Li B; Liu Y; Jiang M
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1999 Feb; 21(1):8-12. PubMed ID: 12569633
[TBL] [Abstract][Full Text] [Related]
16. Epstein-Barr virus early antigen diffuse (EBV-EA/D)-directed immunoglobulin A antibodies in systemic lupus erythematosus patients.
Draborg AH; Jørgensen JM; Müller H; Nielsen CT; Jacobsen S; Iversen LV; Theander E; Nielsen LP; Houen G; Duus K
Scand J Rheumatol; 2012 Aug; 41(4):280-9. PubMed ID: 22646970
[TBL] [Abstract][Full Text] [Related]
17. Immunoblotting reactivity of human sera from various sources against purified Epstein-Barr virus.
Ngou J; Segondy M; Graafland H
Res Virol; 1990; 141(1):69-80. PubMed ID: 2158139
[TBL] [Abstract][Full Text] [Related]
18. [Activation of latent infections caused by the Epstein-Barr virus in systemic lupus erythematosus].
Anan'eva LP; Alekberova ZS; Nasonova VA; Stepina VN
Revmatologiia (Mosk); 1986; (1):39-43. PubMed ID: 3012745
[No Abstract] [Full Text] [Related]
19. An unusually high-titer human anti-Epstein Barr virus (EBV) serum and its use in the study of EBV-specific proteins synthesized in vitro and in vivo.
Edson CM; Cohen LK; Henle W; Strominger JL
J Immunol; 1983 Feb; 130(2):919-24. PubMed ID: 6294181
[TBL] [Abstract][Full Text] [Related]
20. Leukocyte migration inhibition detects cross-reacting antigens between cells transformed by Epstein-Barr virus (EBV) and EBV-like simian viruses.
Szigeti R; Rabin H; Timar L; Klein G
Intervirology; 1986; 26(3):121-8. PubMed ID: 3034820
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
